Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00880295 · ClinicalTrials.gov registry record · NA
Patient Outcomes With Endoscopic Versus Open Carpal Tunnel Release
A NA study, sponsored by Penn State University.
- Completed
- Registry status
- NA
- Development phase
- 38
- Enrollment target
NCT00880295: Completed NA study, sponsored by Penn State University.
NCT00880295 is a NA study that has completed, run by Penn State University. The registered enrollment target is 38 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00880295, a NA study, has completed, sponsored by Penn State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 38 participants
- Enrollment target
Study Summary
Although some surgeons prefer one technique rather than the other, both endoscopic and open carpal tunnel release procedures are accepted as standard of care surgeries to relieve carpal tunnel syndrome. The investigator's research is designed to evaluate the significant difference in patient satisfaction between endoscopically-released wrists and open-released wrists. The goal of the study is to compare the two techniques using the following criteria: 1. Primary outcome: patient satisfaction via surveys used in prior publications 2. Secondary outcome: length of time to return to work 3. Secondary outcome: clinical data for recovery from carpal tunnel syndrome including a thorough physical exam and EMG's 4. Secondary outcome: complication rates
Interventions
- PROCEDURE endoscopic carpal tunnel release
- PROCEDURE open carpal tunnel release
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 38 participants |
| Start Date | 2009-03-23 |
| Est. Completion | 2016-07-26 |
| Phase | NA |
What the finished NCT00880295 record still lists
NCT00880295 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 38 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 2 interventions - of which endoscopic carpal tunnel release is the first listed.
NCT00880295 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00880295 about?
NCT00880295 is a clinical study titled "Patient Outcomes With Endoscopic Versus Open Carpal Tunnel Release". Although some surgeons prefer one technique rather than the other, both endoscopic and open carpal tunnel release procedures are accepted as standard of care surgeries to relieve carpal tunnel syndrome. The investigator's research is designed to evaluate the significant difference in patient satisfa...
What is the current status of trial NCT00880295?
This trial is currently completed. It is a NA study. The enrollment target is 38 participants. The study started on 2009-03-23. Estimated completion is 2016-07-26.
What interventions are being tested in trial NCT00880295?
The interventions under investigation include: endoscopic carpal tunnel release (PROCEDURE), open carpal tunnel release (PROCEDURE).
Who is sponsoring clinical trial NCT00880295?
This trial is sponsored by Penn State University, which has 219 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00880295's enrollment target sits among peer trials
38 1538th of 2000 higher than 461 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01684904 · 38 participants · NA
Proton Therapy for Esophageal Cancer
- NCT03310879 · 38 participants · Phase 2
Study of the CDK4/6 Inhibitor Abemaciclib in Solid Tumors Harboring Genetic Alterations in Genes Encoding D-Type Cyclins or Amplification of CDK4 or CDK6
- NCT03896269 · 38 participants · Phase 1
CPX-351 in Treating Patients With Relapsed or Refractory High Risk Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia
- NCT04085315 · 38 participants · Phase 1
Alisertib in Combination With Osimertinib in Metastatic EGFR-mutant Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI